Agfa HealthCares revenues down in 2010 Q1

Michael Bassett | | Health Exec | Precision Medicine
Agfa HealthCare experienced a 5.2 percent drop in revenue in the first quarter of 2010 compared with the same quarter a year ago, from €291 million ($360 million U.S.) in  2009 to €276 million ($342 million U.S.) in 2010.

According to Agfa-Gevaert, due to the economic downturn the seasonal effects in Agfa HealthCare’s markets were greater than usual, resulting in a strong end of 2009, but a lower top line in the first quarter of 2010. The company said its imaging segment has continued to gain market share, even though its revenue decreased in the U.S. and Europe. Also, its IT sales remained stable.

Agfa-Gevaert posted an €18 million ($22 million U.S.) profit in the first quarter of 2010, compared with a €9 million euro ($11 million U.S.) loss in 2009. Revenues were stable—€664 million ($822 million U.S.) in 2010, compared with €662 million ($819 million U.S.) in the first quarter of 2009.

 

 

Michael Bassett,

Contributor

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup